← Back to news
June 29, 2026
Medicare Launches GLP-1 Bridge Program for Weight Loss Drugs with $50 Monthly Copay
- The Medicare GLP-1 Bridge program begins this week, allowing eligible beneficiaries to access GLP-1 medications for obesity at a $50 monthly copay.
- Eligibility includes seniors with a BMI of 35 or higher, or lower BMI with related health conditions, impacting over half of the 56 million Medicare Part D enrollees.
- The program covers three drugs: Zepbound, Wegovy, and Foundayo, but is limited to those whose health is at risk due to obesity, with coverage lasting until December 31, 2027.
3 Sources
- Medicare will soon cover costs of weight-loss drugs. Here’s what you need to knowJun 29, 2026 at 6:31 PM · Independent
- Medicare will start covering obesity drugs for the first time. Here's what patients should knowJun 30, 2026 at 9:00 AM · CNBC
- Medicare will soon cover costs of weight-loss drugs. Here’s what you can expect to pay.Jun 30, 2026 at 3:22 PM · Independent